Khandan Keyomarsi

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification”.

Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification

Journal of Clinical Oncology(2022)10.1200/jco.22.00830

N/A

2.2DataRank · unranked

97 citations

Shuyang Yao, Yuan Yuan, Rebecca A. Previs, Anthony Elias, Richard D. Carvajal +15 more

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2022.7949

N/A

1.4DataRank · unranked

52 citations

Vera J. Suman, Antonino B. D’Assoro, Jodi M. Carter, Karthik V. Giridhar, Brendan P. McMenomy +18 more

Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2− breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00722-1

N/A

0.550DataRank · unranked

18 citations

Nicole M. Kettner, Danielle Kwiatkowski, Senthil Damodaran, Yan Wang, David L. Ramírez +6 more

Phase I safety and efficacy study of autophagy inhibition with hydroxychloroquine to augment the antiproliferative and biological effects of preoperative palbociclib plus letrozole for estrogen receptor-positive, HER2-negative metastatic breast cancer (MBC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.1067

N/A

0DataRank · unranked

3 citations

Danielle Kwiatkowski, Senthil Damodaran, Nicole M. Kettner, David L. Ramírez, Dan S. Gombos +5 more

CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2

Cancer Research(2022)10.1158/0008-5472.can-22-0631

N/A

0DataRank · unranked

11 citations

Yin Wang, Kevin Lin, Varadha Balaji Venkadakrishnan, Martin Bakht, Wei Shi +16 more

Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers

Cancer Research(2023)10.1158/0008-5472.can-23-0705

N/A

0DataRank · unranked

53 citations

Nicole M. Kettner, Xiayu Rao, Cassandra Santaella Bishop, Tuyen Bui, Hannah F. Wingate +10 more

Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0103

N/A

0DataRank · unranked

29 citations

Kurt W. Evans, Maria Gabriela Raso, Ming Zhao, Yasmeen Q. Rizvi, Xiaofeng Zheng +11 more

Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time

Cancer Research(2023)10.1158/0008-5472.can-22-2258

N/A

0DataRank · unranked

4 citations

Yan Wang, Tuyen Bui, Rossana Lazcano, Davis R. Ingram, Min Yi +13 more

Data from Cyclin E Deregulation Impairs Mitotic Progression through Premature Activation of Cdc25C

(2023)10.1158/0008-5472.c.6500210

N/A

0DataRank · unranked

0 citations

Angela Nanos-Webb, Anna Biernacka, Tuyen Bui, Khandan Keyomarsi, Rozita Bagheri‐Yarmand

Data from Cyclin E Deregulation Impairs Mitotic Progression through Premature Activation of Cdc25C

(2023)10.1158/0008-5472.c.6500210.v1

N/A

0DataRank · unranked

0 citations

Angela Nanos-Webb, Anna Biernacka, Tuyen Bui, Khandan Keyomarsi, Rozita Bagheri‐Yarmand

Data from Farnesyl and Geranylgeranyl Transferase Inhibitors Induce G1 Arrest by Targeting the Proteasome

(2023)10.1158/0008-5472.c.6494891.v1

N/A

0DataRank · unranked

0 citations

Khandan Keyomarsi, Ekem T. Efuet

Data from Farnesyl and Geranylgeranyl Transferase Inhibitors Induce G1 Arrest by Targeting the Proteasome

(2023)10.1158/0008-5472.c.6494891

N/A

0DataRank · unranked

0 citations

Khandan Keyomarsi, Ekem T. Efuet

Data from Low-Molecular-Weight Cyclin E Can Bypass Letrozole-Induced G1 Arrest in Human Breast Cancer Cells and Tumors

(2023)10.1158/1078-0432.c.6517767

N/A

0DataRank · unranked

0 citations

Tuyen Bui, Hannah F. Wingate, Anna Biernacka, Stacy Moulder, Susan L. Tucker +3 more

Data from Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer

(2023)10.1158/1078-0432.c.6529199

N/A

0DataRank · unranked

0 citations

Smruthi Vijayaraghavan, Merih Güray Durak, Tuyen Bui, Mehrnoosh Kohansal, Min Jin Ha +17 more

Data from Low-Molecular-Weight Cyclin E Can Bypass Letrozole-Induced G1 Arrest in Human Breast Cancer Cells and Tumors

(2023)10.1158/1078-0432.c.6517767.v1

N/A

0DataRank · unranked

0 citations

Tuyen Bui, Hannah F. Wingate, Anna Biernacka, Stacy L. Moulder, Susan L. Tucker +3 more

Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance

Nature Communications(2024)10.1038/s41467-023-44412-7

N/A

0DataRank · unranked

133 citations

Amber D. Horbath, Lavanya Kondiparthi, Jitendra K. Meena, Guang Lei, Shayani Dasgupta +12 more

Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics

Cancers(2024)10.3390/cancers16030492

N/A

0DataRank · unranked

21 citations

Debasish Tripathy, Kelly K. Hunt, Khandan Keyomarsi, Taiwo Adesoye

STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response

Leukemia(2024)10.1038/s41375-024-02218-6

N/A

0DataRank · unranked

5 citations

Yifan Zhou, Rachel L. Babcock, Feiyang Ma, Malgorzata Anna Zal, Dhiraj Kumar +15 more

IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer

npj Precision Oncology(2025)10.1038/s41698-025-01041-1

N/A

0DataRank · unranked

14 citations

Tuyen Bui, Juliana Navarro-Yepes, Sanaz Ghotbaldini, Bethanie Quintela, Catherine K. Luo +19 more

FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer models

Journal of Clinical Investigation(2025)10.1172/jci173757

N/A

0DataRank · unranked

4 citations

Hirohito Yamaguchi, Yuan Gao, Weiya Xia, Jeffrey T. Chang, Yu‐Chun Hsiao +27 more

Specific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancer

British Journal of Cancer(2020)10.1038/s41416-019-0707-z

N/A

0DataRank · unranked

18 citations

J. Andrew Livingston, Nalini Patel, Tuyen Bui, Kelly K. Hunt, Khandan Keyomarsi +1 more

Rb1 deficiency induces synthetic lethality with ATR and PKMYT1 coinhibition in breast cancer cell lines and patient-derived xenografts

Science Translational Medicine(2025)10.1126/scitranslmed.adx6797

N/A

0DataRank · unranked

2 citations

Mei-Kuang Chen, J.J. Lee, Xiayu Rao, Yan Wang, Linjie Luo +4 more

Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration

Cancers(2021)10.3390/cancers13071656

N/A

0DataRank · unranked

26 citations

Dong Yang, Jason P.W. Carey, Cansu Karakaş, Constance T. Albarracin, Ayşegül A. Şahin +9 more

LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers

Oncogenesis(2021)10.1038/s41389-021-00324-z

N/A

0DataRank · unranked

6 citations

Saïd Akli, Cansu Karakaş, Min Jin Ha, Natalie W. Fowlkes, Yoshitsugu Mitani +8 more